Field Trial of the Use of Propionibacterium Acnes, Immunostimulant in the Treatment of Acute Clinical Mastitis

Authors

  • R. P. Dinsmore Department of Clinical Sciences, Colorado State University, Fort Collins, CO
  • M. D. Salman Department of Clinical Sciences, Colorado State University, Fort Collins, CO
  • M. B. Cattell Department of Clinical Sciences, Colorado State University, Fort Collins, CO

Keywords:

antibiotic residues, clinical mastitis, immune modulators, Propionibacterium acnes

Abstract

Heightened public concern over the presence of antibiotic residues has forced the dairy industry to consider alternatives to antimicrobials in the treatment of clinical mastitis. One such alternative is the use of immune modulators which enhance cell mediated immunity and lymphokine production (Cox 1988; McCall 1989). Anecdotal reports indicated that a killed extract of Propionibacterium acnes (Propionibacterium Acnes, Immunostimulant; ImmunoVet Inc) was being successfully used to treat chronic clinical mastitis (Douglas 1990). However, no controlled trials have yet been reported that document the success of this treatment.

Cover image of the 26th Conference Proceedings: A photo of the Albuquerque skyline during midday. In the foreground are skyscrapers, the scene is dotted with trees and scrub land, and a mountain rises behind the city. Yellow background.

Downloads

Published

1993-09-16

Issue

1993

Section

Research Summaries 2